Theravance Biopharma Inc.
Theravance Biopharma, Inc. develops YUPELRI, a nebulized LAMA for COPD, and Ampreloxetine for neurogenic orthostatic hypotension in MSA. It partners with Viatris on revefenacin, expanding its specialty‑pharma pipeline.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Manufacturing
- Industry: Pharmaceutical Manufacturing
- Employees: 97
- HQ: South San Francisco
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.